• Title/Summary/Keyword: Stage I and II

Search Result 1,178, Processing Time 0.028 seconds

Surgical Treatment For Primary Non-Small Cell Lung Cancer (원발성 비소세포성 폐암의 외과적 치료)

  • 최준영;김병균
    • Journal of Chest Surgery
    • /
    • v.30 no.9
    • /
    • pp.908-913
    • /
    • 1997
  • From May 1988 to December 1995, 77 patients underwent surgical re ection for primary non-small cell lung cancer at GNUH, and were evaluated clinically. There were 65 males and 12 females(M:P=5.4:1), and the peak incidence of age was 6th decade of life(44.5%). The major symptoms were cough, hemoptysis and chest pain due to anatomical effects of the mass. Histopathologically, squamous cell carcinoma was 81.8%, adenocarcinoma 14.3%, and adenosquamous carcinoma 3.9% . There was no significant difference in survival among three groups. The pneumonectomy was performed in 26 cases(33.8%), lobectomy 30 cases(38.9%), bilobectomy 9 cases(11.7%), and overall resectability was 84.4%. The postoperative official stagings were as follows ; 26 patients of stage I(34%), 14 patients of stage II(18%), 22 patients of stage IIIa(29%), 14 patients of stage IIIb(18%), and one patients of stage IV(1%). In all cases, 3 year survival rate are showed stage 183%, stage II 26%, stage IIIa 17%, and stage IIIb 0%.

  • PDF

Assisted Reproductive Technology in Infertile Patients with Endometriosis (자궁내막증과 동반된 불임환자의 보조생식술을 이용한 치료)

  • Moon, Shin-Yong;Lee, Kyung-Soon;Roh, Jae-Sook;Suh, Chang-Suk;Kim, Seok-Hyun;Choi, Young-Min;Shin, Chang-Jae;Kim, Jung-Gu;Lee, Jin-Young;Chang, Yoon-Seok
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.22 no.2
    • /
    • pp.211-220
    • /
    • 1995
  • Though the endometriosis is not always related with infertility, endometriosis causes infertility in some patients. There are many treatment modalities of infertile patients who have endometriosis. In recent years, Assisted Reproductive Technology(ART) have been widely accepted as being a useful tool for the treatment of infertile endometriotic patients. The objective of this study was to evaluate the outcome of ART in infertile endometriotic patients who have been carried out IVF-ET from Jan, 1992 to Dec, 1994 and to compare the results between COH/IUI and IVF-ET in the patients with endometriosis stage I. Tubal disease only patients were grouped(308 patient, 956 cycles) as a control. Endometriosis group was subdivided into 4 groups according to American Fertility Society classification; endometriosis stage I (45 patients, 61 cycles), stage II (26 patients, 39 cycles), stage III (26 pateitns, 37 cycles), stage IV (33 patients, 50 cycles). The outcomes of IVF-ET in endometriosis patients were as follows; The oocyte recovery rates were significantly lower in stage III, IV endometriosis. In case of stage III endometriosis, the fertilization rate was significantly lower than other stages of endometriosis. Clinical pregnancy rates per cycle were not different between the tubal group(22%) and the endometriosis group(25%). According to endometriosis stage, the implantation rate and clinical pregnancy rate were significantly lower in stage IV (5.6%, 16%) compared with other stages (I; 10.0%, 26%, II;9.8%, 31%, III;12.6%, 32%). It suggests that some factor like autoantibodies may inhibit implantation of embryos in stage IV endometriosis. To evaluate the possibility that simply increasing the number of gametes at the site of fertilization might account for pregnancies attributed to IVF-ET, the authors retrospectively analyzed the outcome of couples undergoing IUI during hMG cycles and CC cycles between 1992 and 1994 in the women with endometriosis stage 1. In case of stage I endometriosis, though the COH/IUI group showed lower FSH level and lesser age profile than IVF-ET group, IUI group has resulted in lower pregnancy rates(19.2%) compared with the IVF-ET group(26.2%). In conclusion, endometriotic infertile patients can get comparable pregnancy rates with the tubal factor infertility patients during IVF-ET program. Moreover even in stage I endometriosis, IVF-ET may be an more effective treatment modality than COH/IUI.

  • PDF

Variations of Gonadotropin Subunits mRNA Levels at Different Stages of Ovarian Development in Masu Salmon, Oncorhynchus masou

  • Kim Dae-Jung;Han Chang-Hee;Aida Katsumi
    • Fisheries and Aquatic Sciences
    • /
    • v.2 no.2
    • /
    • pp.176-181
    • /
    • 1999
  • The variations of gene expression and pituitary contents of GTH subunits during the ovarian development of masu salmon, Oncorhynchus masou, were investigated. The pituitary GTHs contents was measured by radioimmunoassays (RIAs) using purified GTH subunits and their antibodies. Pituitary contents of GTH $I\beta$ gradually increased from April through August, and reached the maximum in October. On the other hand, pituitary contents of GTH $II\beta$ remained low until August, but they rapidly increased in October. Total RNAs were prepared from pooled pituitaries and the GTH subunits mRNA in pituitaries was quantified by Northern blot hybridization using masu salmon cDNA probes for each GTH subunit. GTH $I\beta$ mRNA level increased with the progression of ovarian maturity. However, GTH $II\beta$ mRNA was detected only at a more advanced stage, and were extremly high at ovulation. A high levels for GTH a mRNA was detected only at ovulation stage. The synchronous increase in pituitary contents and mRNA levels suggested that ovarian maturity in masu salmon was regulated by both GTH I and GTH II.

  • PDF

Meiosis and Postmeiotic Mitosis in Boletus rubinellus (Boletus rubinellus에서 감수분열 및 감수분열후 유사분열)

  • 윤권상
    • Journal of Plant Biology
    • /
    • v.30 no.4
    • /
    • pp.225-247
    • /
    • 1987
  • Meiosis and postmeiotic mitosis in Boletus rubinellus were examined ultrastructurally. Meriosis occurred at the apex of the basidium. A sausage-shaped spindle pole body(SPB) was observed along with the presence of synaptonemal complexes during pachytene and a diglobular SPB was present on late pachytene or diplotene nuclei. During metaphase I, the monoglobular SPB at the spindle pole was surrounded bya membrane and the nuclear enveloope was discontinuous. At anaphase I, the chromosomes became better defined and formed a central spindle. The nucleolus was extruded from the nucleus. During anaphase I, the SPB was excluded from the chromosomal region by a membrane and both poles were fully separated to opposite sides of the basidial wall. In meiosis II, the two nuclei divided synchronously and the spindles were parallel. The spindles were smaller than in meiosis I, while the SPB was approximately the same size as that of the similar stage in meiosis I. During anaphasetelophase II, the SPB was surrounded by a cap of endoplasmic reticulum (ER) that delimited it from the spindle. The postmeiotic interphase nuclei migrated to the mid-region of the basidium before migration to the spores. The SPB at this stage was diglobular. A postmeiotic mitosis occurred within the basidiospore, and the plane of the spindle was obique to the long axis of the spore. The spindle and SPB were smaller than at meiosis I and there were fewer nonchromosomal microtubules. At anaphase, the nucleolus was present inside the nuclear envelope but lateral to the spindle.

  • PDF

Chemical Composition of Sphalerite Relating to Mineralization at the Tongyoung mine, Korea (통영광산산(統營鑛山産) 섬아연석(閃亞鉛石)의 화학조성(化學組成))

  • Kim, Moon Young;Shin, Hong Ja
    • Economic and Environmental Geology
    • /
    • v.22 no.2
    • /
    • pp.103-115
    • /
    • 1989
  • The Tongyoung deposits are epithermal gold and silver bearing quartz-rhodochrosite vein type deposits of late Cretaceous. They occurs in the andesite and tuff breccia member called Gyeongsang basin. Four mineralizations can be distinguished at the mine based on macrostructures. From earlist stage to lastest stage they are: stage I, base-metal quartz vein; stage II, rhodochrosite vein (IIA) and Pb-Zn vein (IIB); stage III, barren quartz vein; stage IV, calcite-ankeritic rhodochrosite veins. Gold and silver mineralizations occur predominantly in the stage I and IIB. Electrum is closely associated with galena, sphalerite and pyrite, and has chemical compositions of 50.98-64.05 atom % Ag. Sphalerite contains 2.09-5.05 mol % FeS and 0.34-2.01 mol % MnS in the stage I, and 2.01-3.41 mol % FeS and 0.21-2.80 mol % MnS in the stage IIB. The FeS and MnS contents are in general correlated, and shows a characteristic zonal arrangement of electrum. It reveals rhat FeS contents of sphalerite which precipitated before electrum, gradually decreases in a grain during its deposition ranging from about 3.3 to 2 mol %. It may be considered from the above data that an increase of $fs_2$ caused by the oxidation of ore forming fluid is more important that the decrease of temperature.

  • PDF

Geomorphic Development of Marine Terraces at Jeongdongjin-Daejin area on the East Coast, Central Part of Korean Peninsula (한반도 중부 동해안 정동진, 대진지역의 해안단구 지형발달)

  • 윤순옥;황상일;반학균
    • Journal of the Korean Geographical Society
    • /
    • v.38 no.2
    • /
    • pp.156-172
    • /
    • 2003
  • In this paper we identify that there are High Higher surfaces(HH-surface) around Jeongdongjin and Daejin area where Higher surfaces(H-surface) of marine terrace are formed on a large scale. On the basis of an altitude of the ancient shoreline of the marine terraces, geomorphic surfaces can be classified into HH I (140m a.s.l), HH II (110m a.s.l), H I (90m a.s.l), H II (70m a.s.l), M (40m a.s.l), L I (25m a.s.l) and L II (10m a.s.l). Besides, we identify that the lowest surfaces(5~6m a.s.l) are found extensively in the research area which are assumed to be formed in the Holocene. Considering that the formation mechanism of the marine terraces in the research area is similar to that of the marine terraces at both Campo area in the south east coastal region of Korea md the thalassostatic terraces of Osip River in Samchuk in a short distance from the research area, we can assume that the HH-surfaces in both areas were formed in the same period. Based on the fact that L I- surface was formed on the Last Interglacial Stage of MIS 5, we can infer that M- was formed in MIS 7, H I- in MIS 9, H II- in MIS 11, HH I- in MIS 13 and HH II- in MIS 15. The reason for that H-surfaces, similar to those at Gampo area, to remain on a large scale is that the Holsteinian Interglacial continued for a long period of time and at that time there was a large wave-cut platform in the vicinity of the shoreline.

Treatment Results for Supraglottic Cancer (성문상부암의 치료결과)

  • Lee, Kyu-Chan;Kim, Chul-Yong;Choi, Myung-Sun
    • Radiation Oncology Journal
    • /
    • v.12 no.3
    • /
    • pp.323-329
    • /
    • 1994
  • Purpose: In supraglottic cancer, radiation therapy is used to preserve the laryngeal function but combined surgery and radiation therapy is required in advanced stage. The authors Present the results of radiation therapy alone and combined surgery Plus Postoperative radiation therapy for supraglottic cancer. Methods and Materials: A retrospective analysis was done for 43 patients with squamous cell carcinoma of the supraglottic larynx who were treated from Feburary 1982 to December 1991, in the Department of Radiation Oncology, Korea University Hospital. Patient distribution according to the AJCC staging system was as follows: I, 3($7.0\%$); II, 7($16.3\%$); III, 17($39.5\%$); IV, 16($37.2\%$). Patients' age ranged from 30 to 72 years(median 62). Follow up durations were from 21 to 137 months(median 27). Seventeen patients($39.5\%$) were treated by radiation therapy alone with radiation doses of 6840-7380 cGy and 26 patients($60.5\%$) were treated with surgery plus postoperative irradiation with doses of 5820-6660 cGy. Results: Overall five-year survival rate for all stage was $51.8\%$, with $100\%$ for Stage I and II, $47.3\%$ for Stage III, and $29.2\%$ for Stage III. The difference of the survival rate by stage was statistically significant(p=0.0152). Five-year survival rates were $100\%$ for locally confined tumor in the supraglottic larynx, $37.5\%$ for transglottic extension, $26.7\%$ for hypopharynx extension, and only two of 5 patients with both transglottic and hypopharynx extension were alive(p=0.0033). Five-year survival rates by neck node status were as follows: $55.0\%$ for NO, $64.3\%$ for N1, $50.0\%$ for N2, and all 2 of N3 were died of disease. Overall survival rate for radiation therapy alone group was $42.8\%$, and it was $56.7\%$ for surgery plus postoperative radiation therapy group with no statistically significant difference(p=0.5215). In Stage I and II, all Patients survived. In Stage III and IV, 5-year survival rate for radiation therapy alone group was $28.5\%$ and $43.4\%$ for surgery plus postoperative irradiation group(p=0.5103). Local control rate was $58.8\%$(10/17) for radiation therapy alone group and $73.1\%$ (19/26) for surgery plus postoperative irradiation group. Three patients from surgery plus postoperative radiation therapy group developed distant metastasis in lungs. Conclusion: Treatment results of radiation therapy alone was excellent in early stage supraglottic cancer. In advanced stage, even the difference was statistically not significant, the result of postoperative radiation therapy group was superior compared with radiation therapy alone group. Since 1992, concomitant chemoradiotherapy with hyperfractionated radiotherapy is being used to improve the result of the treatment and preserve the laryngeal function in advanced stage supraglottic cancer.

  • PDF

Surgical Treatment of Thymoma (흉선종의 외과적 치료)

  • Jang, Jae-Han;Kim, Min-Ho;Jo, Jung-Gu
    • Journal of Chest Surgery
    • /
    • v.29 no.4
    • /
    • pp.427-432
    • /
    • 1996
  • Eighteen patients operated on for thymoma from 1985 to 1994 were evaluated, 3 with myasthenia gravis and 15 without. Masaoka's clinical staging revealed stage I disease in 5(27.8%), stage ll in 6 (33.3%), stage 111 in 6(33.3%), and stage IV in 1 (5.6%). Of the 18 patients, 10 had surgical resection as the only treatment and the remaining 8 (stage II : 1 patient, stage III : 6 patients, stage IV: 1 patient) had surgical resection with adjuvant preoperative or postoperative radiotherapy and/or chemotherapy There was no operative mortality. Currently, 15 patients are alive, 3 are dead. The mean follow up time for all patients was 3.4 years. Acturlal survival at 5 years was 82.2 $\pm$ 9% for all patients' 100% for those in stage I and II, and 62.5% for those in stage III. Pleural and mediastinal recurrence developed in one patient in stage II which was considered to have noninvasive disease on the operating field. Two patients underwent reoperation for recurrence of thymoma a intervals of 14 months and 52 months. Clinical stage and resectability had a significant prognostic value(p < 0.05). The presence of myasthenia gravis is no longer considered as an adverse factor in survival.

  • PDF

Serum CA 125 Levels in Patients with Endometriosis (자궁내막증 환자에서 혈청 CA 125치 동태에 관한 연구)

  • Lee, Jin-Yong;Yoon, Byung-Koo;Choi, Young-Min;Sin, Chang-Jae;Chang, Yoon-Seck
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.17 no.2
    • /
    • pp.101-106
    • /
    • 1990
  • Serum CA 125 was measured with immunoradiometric assay in fourty-one patients of endometriosis Serum CA 125 levels (Mean ${\pm}$ SEM, U/ml)in patients with endometriosis were 13.8${\pm}$3.3 in stage I , 17.3${\pm}$3.0 in stage II, 23.4${\pm}$4.9 in stage III, and 64.5${\pm}$13.2 in stage IV, which showed increment according to the stage of endometriosis. Serum levels in stage IV only were significantly elvated than those in control (15.3${\pm}$2.2), and those in advanced stage(III and IV ; 47.1${\pm}$9.5)were significantly higher than those in earlier stages (15.9${\pm}$2.2)and control. The assay revealed a sensitivity of 31.7% and the frequency of elevated levels (> 30.3 U/ml)in stage I, II, III and IV was 9. 1%, 18.8%,33.3%, and 87.5% respectively. Sensitivity in advanced stage was higher than that in earlier stage (64.3% vs. 14.8%). There data suggest that serum CA 125 assay might be a useful diagnostic tool in the advanced stage of endometriosis.

  • PDF

Changes of Mortality and Morbidity of Very Low Birth Weight Infants after Neonatal Intensive Care Unit Strategy Alteration in a Single Center: Comparison with 2015 Korean Neonatal Network Report

  • Jung, Seung Mi;Seok, Min Jeong;Chun, Ji Yong;Sung, Tae-Jung
    • Neonatal Medicine
    • /
    • v.25 no.1
    • /
    • pp.29-36
    • /
    • 2018
  • Purpose: The purpose of this study was to investigate the outcome after changes in the treatment strategies for very low birth weight infant (VLBWI) in a single neonatal intensive care unit (NICU) center. Methods: We performed a retrospective review of 300 VLBWI born from 1st January 2010 to 31th December 2016. We compared the outcomes including survival rate, birth weight (BW), gestational age (GA), and morbidities between period I (2010-2013, P-I) and period II (2014-2016, P-II). Results: The average survival rate was not different between P-I and P-II. However, the survival rate of ${\leq}24$ weeks' GA, 25 weeks' GA, 26 weeks' GA were 57%, 69%, 93% respectively in P-II and 31%, 59%, 87% in P-I respectively. The survival rate of infants with birth weight <500 g, 500-749 g, 750-999 g were 100%, 55%, 90% respectively in P- II and 50%, 24%, 80%, respectively in P-I. The incidence of bronchopulmonary dysplasia (BPD) was higher in P-II than in P-I (P=0.012) and moderate-to-severe BPD was also higher in P-II (P=0.004). Incidence of patent ductus arteriosus (PDA) with treatment, necrotizing enterocolitis (stage ${\geq}2$), and abnormal brain sonography were significantly lower in P-II (P=0.027, P=0.032, P=0.005). Incidences of retinopathy of prematurity (ROP) with laser treatment and early sepsis were not different. Conclusion: The survival rate and complications of VLBWI were improved in period II, especially in less than 750 g and below 26 weeks, except incidence of BPD. Changes of NICU strategies were effective to improve mortality and morbidity in VLBWI.